Figure 1.
Distribution of donor-specific anti-HLA antibodies in kidney transplant recipients. rCXM+, patients with positive remote CDCXM; rCXM−, patients with negative remote CDCXM; peak HLA-DSA Luminex+, patients with donor-specific HLA antibodies detected by SAFB Luminex technique on the peak sera; peak HLA-DSA Luminex−, patients without donor-specific HLA antibodies detected by SAFB Luminex technique on the peak sera.